Effect of milrinone on the inflammatory response and NF-kB activation in renal ischemia-reperfusion injury in mice

Korean Journal of Anesthesiology

Volumn 66, Issue 2, 2014, Pages 136-142

  Jung, Hong Soo ^a   Joo, Jin Deok ^a   Kim, Dae Woo ^a   In, Jang Hyeok ^a   Roh, Misun ^a   Jeong, Jong Tae ^a   Noh, Seung June ^b   Choi, Jin Woo ^a  

^a Department of Anesthesiology and Pain Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Ischemia reperfusion injury; Milrinone; Nuclear factor kappa B

Indexed keywords

CREATININE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MACROPHAGE INFLAMMATORY PROTEIN 2; MILRINONE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HISTOLOGY; INFLAMMATION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; MOUSE; NEPHRECTOMY; NONHUMAN; PROTEIN EXPRESSION; RADIOIMMUNOPRECIPITATION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84901740525     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2014.66.2.136     Document Type: Article

References (26)

1. Joo JD, Kim DW, Kang YJ, Kim YS, Jeon YS, In JH, et al. Renal protective effects of opposite renal ischemic preconditioning against renal ischemic reperfusion injury in mice. Korean J Anesthsiol 2007; 53: 229-33.
2. Fan H, Sun B, Gu Q, Lafond-Walker A, Cao S, Becker LC. Oxygen radicals trigger activation of NF-kappa B and AP-1 and upregulation of ICAM-1 in reperfused canine heart. Am J Physiol Heart Circ Physiol 2002; 282: H1778-86.
3. Wan F, Lenardo MJ. The nuclear signaling of NF-kB: current knowledge, new insights, and future perspectives. Cell Res 2010; 20: 24-33.
4. Häcker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006; 357: re13.
5. Senftleben U, Karin M. The IKK/NF-kB pathway. Crit Care Med 2002; 30(1 Suppl): S18-26.
6. Boswell-Smith V, Spina D, Page CP. Phosphodiesterase inhibitors. Br J Pharmacol 2006; 147(Suppl 1): S252-7.
7. Lanfear DE, Hasan R, Gupta RC, Williams C, Czerska B, Tita C, et al. Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure. J Transl Med 2009; 7: 67.
8. Nishiki T, Kitada H, Okabe Y, Miura Y, Kurihara K, Kawanami S, et al. Effect of milrinone on ischemic-reperfusion injury in the rat kidney. Transplant Proc 2011; 43: 1489-94.
9. Jablonski P, Howden BO, Rae DA, Birrel CS, Marshall VC, Tange J. An experimental model for assessment of renal recovery from warm ischemia. Transplantation 1983; 35: 198-204.
10. Levy JH, Ramsay J, Bailey JM. Pharmacokinetics and pharmacodynamics of phosphodiesterase-III inhibitors. J Cardiothorac Anesth 1990; 4(Suppl 5): 7-11.
11. Kume M, Banafsche R, Yamamoto Y, Yamaoka Y, Nobling R, Gebhard MM, et al. Dynamic change of post-ischemic hepatic microcirculation improved by a pre-treatment of phosphodiesterase-3 inhibitor, Milrinone. J Surg Res 2006; 136: 209-18.
12. Satoh K, Kume M, Abe Y, Uchinami H, Yakubouski SV, Takahashi T, et al. Implication of protein kinase A for a hepato-protective mechanism of milrinone pretreatment. J Surg Res 2009; 155: 32-9.
13. Craciun EM, Altfelder F, Kuss N, Poeschl J, Ruef P. Anti-inflammatory effects of selected drugs on activated neonatal and adult neutrophils. Scand J Clin Lab Invest 2013; 73: 407-13.
14. Comerford KM, Lawrence DW, Synnestvedt K, Levi BP, Colgan SP. Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junction permeability. FASEB J 2002; 16: 583-5.
15. Schäfer A, Burkhardt M, Vollkommer T, Bauersachs J, Münzel T, Walter U, et al. Endothelium-dependent and -independent relaxation and VASP serines 157/239 phosphorylation by cyclic nucleotide-elevating vasodilators in rat aorta. Biochem Pharmacol 2003; 65: 397-405.
16. Qiao J, Huang F, Lum H. PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2003; 284: L972-80.
17. Semmler J, Gebert U, Eisenhut T, Moeller J, Schönharting MM, Alléra A, et al. Xanthine derivatives: comparison between suppression of tumor necrosis factor-alpha production and inhibition of c-AMP phosphodiesterase activity. Immunology 1993; 78: 520-5.
18. Jaeschke H, Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver Int 2006; 26: 912-9.
19. Lalor PF, Sun PJ, Weston CJ, Martin-Santos A, Wakelam MJ, Adams DH. Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappa B-dependent increase in lymphocyte adhesion. Hepatology 2007; 45: 465-74.
20. Bombeli T, Mueller M, Haeberli A. Anticoagulant properties of the vascular endothelium. Thromb Haemost 1997; 77: 408-23.
21. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000; 190: 255-66.
22. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99: 2682-90.
23. McDougal WS. Renal perfusion/reperfusion injuries. J Urol 1988; 140: 1325-30.
24. Lee SO, Jeong YJ, Yu MH, Lee JW, Hwangbo MH, Kim CH, et al. Wogonin suppresses TNF-alpha-induced MMP-9 expression by blocking the NF-kappaB activation via MAPK signaling pathways in human aortic smooth muscle cells. Biochem Biophys Res Commun 2006; 351: 118-25.
25. Wright JL, Tai H, Wang R, Wang X, Churg A. Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-alpha signaling. Am J Physiol Lung Cell Mol Physiol 2007; 292: L125-33.
26. Rodriguez M, Cabal-Hierro L, Carcedo MT, Iglesias JM, Artime N, Darnay BG, et al. NF-kappaB signal triggering and termination by tumor necrosis factor receptor 2. J Biol Chem 2011; 286: 22814-24.